Figure 2.
Overall outcomes of FLT3-mutated AML treated with sorafenib. Kaplan-Meier curves for OS (A), DFS (B), and EFS (C).

Overall outcomes of FLT3-mutated AML treated with sorafenib. Kaplan-Meier curves for OS (A), DFS (B), and EFS (C).

Close Modal

or Create an Account

Close Modal
Close Modal